OPTUS PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,140 KRW | +1.49% |
|
+3.37% | +15.41% |
| Sales 2022 | 58.66B 42.64M 3.56B | Sales 2023 | 72.43B 52.65M 4.39B | Capitalization | 85.93B 62.47M 5.21B |
|---|---|---|---|---|---|
| Net income 2022 | 5.01B 3.64M 304M | Net income 2023 | 10.76B 7.82M 653M | EV / Sales 2022 | 0.73 x |
| Net cash position 2022 | 58.96B 42.86M 3.58B | Net cash position 2023 | 66.45B 48.31M 4.03B | EV / Sales 2023 | 0.27 x |
| P/E ratio 2022 |
19.9
x | P/E ratio 2023 |
7.51
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 54.31% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.49% | ||
| 1 week | +3.37% | ||
| Current month | -12.66% | ||
| 1 month | -16.01% | ||
| 3 months | +16.07% | ||
| 6 months | +24.04% | ||
| Current year | +15.41% |
1 week
6 010.00
6 290.00
1 month
5 760.007 700.00
Current year
5 040.009 550.00
1 year
4 465.009 550.00
3 years
4 465.009 550.00
5 years
4 465.0010 150.00
10 years
4 465.0017 600.00
| Managers | Title | Age | Since |
|---|---|---|---|
Eun-Young Park
CEO | Chief Executive Officer | 49 | - |
Sang-Hak Choi
CTO | Chief Tech/Sci/R&D Officer | 56 | - |
Young-Woon Park
BRD | Director/Board Member | 58 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Woo-Seok Koh
BRD | Director/Board Member | 65 | - |
Tae-Eun Jang
BRD | Director/Board Member | 62 | 10/13/10 |
Young-Woon Park
BRD | Director/Board Member | 58 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/24/29 | 6,330 | +3.09% | 256,219 |
| 26/24/26 | 6,140 | +1.49% | 192,907 |
| 25/24/25 | 6,050 | -2.89% | 180,353 |
| 24/24/24 | 6,230 | +3.15% | 251,425 |
| 23/24/23 | 6,040 | 0.00% | 164,096 |
End-of-day quote Korea S.E., April 26, 2024
More quotes
Optus Pharmaceutical Co Ltd, formerly DHP Korea Co Ltd, is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company is primarily engaged in the manufacture and sale of eye drops and ophthalmic preparations such as dry eye treatment agents, conjunctivitis treatment agents, anti-inflammatory medication agents, glaucoma treatment agents and others.
Sector
Pharmaceuticals
Calendar
13/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +15.41% | 72.06M | |
| +4.06% | 70.44B | |
| +10.97% | 8.94B | |
| -16.83% | 4.75B | |
| +43.48% | 4.5B | |
| +3.20% | 3.85B | |
| +23.46% | 2.38B | |
| -21.36% | 2.34B | |
| -29.67% | 2.2B | |
| +8.38% | 1.96B |
- Stock Market
- Equities
- A131030 Stock
